The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fully Bioresorbable Stents-Global Market Insights and Sales Trends 2024
Synopsis
The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation in the body, and can restore the function and elasticity of blood vessels without permanent retention.
The global Fully Bioresorbable Stents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fully Bioresorbable Stents in various end use industries. The expanding demands from the Hospital, Surgical Centers and Others,, are propelling Fully Bioresorbable Stents market. Below 100μm, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100-150μm segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fully Bioresorbable Stents market, driven by demand from China, the second largest economy with some signs of stabilising, the Fully Bioresorbable Stents market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fully Bioresorbable Stents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fully Bioresorbable Stents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fully Bioresorbable Stents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fully Bioresorbable Stents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fully Bioresorbable Stents covered in this report include Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation and Biotronic, etc.
The global Fully Bioresorbable Stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Lepu Medical Technology
Shandong Hua'an Biotechnology
MicroPort
Lifetech Scientific
Beijing Advanced Medical Technologies
Shanghai Bio-heart Biological Technology
Elixir Medical Corporation
Biotronic
Global Fully Bioresorbable Stents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fully Bioresorbable Stents market, Segment by Type:
Below 100μm
100-150μm
More than 150μm
Global Fully Bioresorbable Stents market, by Application
Hospital
Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fully Bioresorbable Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fully Bioresorbable Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation in the body, and can restore the function and elasticity of blood vessels without permanent retention.
The global Fully Bioresorbable Stents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fully Bioresorbable Stents in various end use industries. The expanding demands from the Hospital, Surgical Centers and Others,, are propelling Fully Bioresorbable Stents market. Below 100μm, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100-150μm segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fully Bioresorbable Stents market, driven by demand from China, the second largest economy with some signs of stabilising, the Fully Bioresorbable Stents market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fully Bioresorbable Stents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fully Bioresorbable Stents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fully Bioresorbable Stents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fully Bioresorbable Stents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fully Bioresorbable Stents covered in this report include Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation and Biotronic, etc.
The global Fully Bioresorbable Stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Lepu Medical Technology
Shandong Hua'an Biotechnology
MicroPort
Lifetech Scientific
Beijing Advanced Medical Technologies
Shanghai Bio-heart Biological Technology
Elixir Medical Corporation
Biotronic
Global Fully Bioresorbable Stents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fully Bioresorbable Stents market, Segment by Type:
Below 100μm
100-150μm
More than 150μm
Global Fully Bioresorbable Stents market, by Application
Hospital
Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fully Bioresorbable Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fully Bioresorbable Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Fully Bioresorbable Stents Market Overview
1.1 Fully Bioresorbable Stents Product Overview
1.2 Fully Bioresorbable Stents Market Segment by Type
1.2.1 Below 100μm
1.2.2 100-150μm
1.2.3 More than 150μm
1.3 Global Fully Bioresorbable Stents Market Size by Type
1.3.1 Global Fully Bioresorbable Stents Market Size Overview by Type (2018-2029)
1.3.2 Global Fully Bioresorbable Stents Historic Market Size Review by Type (2018-2023)
1.3.3 Global Fully Bioresorbable Stents Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fully Bioresorbable Stents Sales Breakdown by Type (2018-2023)
1.4.2 Europe Fully Bioresorbable Stents Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Fully Bioresorbable Stents Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Fully Bioresorbable Stents Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Fully Bioresorbable Stents Sales Breakdown by Type (2018-2023)
2 Global Fully Bioresorbable Stents Market Competition by Company
2.1 Global Top Players by Fully Bioresorbable Stents Sales (2018-2023)
2.2 Global Top Players by Fully Bioresorbable Stents Revenue (2018-2023)
2.3 Global Top Players by Fully Bioresorbable Stents Price (2018-2023)
2.4 Global Top Manufacturers Fully Bioresorbable Stents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fully Bioresorbable Stents Market Competitive Situation and Trends
2.5.1 Fully Bioresorbable Stents Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Fully Bioresorbable Stents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fully Bioresorbable Stents as of 2022)
2.7 Date of Key Manufacturers Enter into Fully Bioresorbable Stents Market
2.8 Key Manufacturers Fully Bioresorbable Stents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Fully Bioresorbable Stents Status and Outlook by Region
3.1 Global Fully Bioresorbable Stents Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Fully Bioresorbable Stents Historic Market Size by Region
3.2.1 Global Fully Bioresorbable Stents Sales in Volume by Region (2018-2023)
3.2.2 Global Fully Bioresorbable Stents Sales in Value by Region (2018-2023)
3.2.3 Global Fully Bioresorbable Stents Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Fully Bioresorbable Stents Forecasted Market Size by Region
3.3.1 Global Fully Bioresorbable Stents Sales in Volume by Region (2024-2029)
3.3.2 Global Fully Bioresorbable Stents Sales in Value by Region (2024-2029)
3.3.3 Global Fully Bioresorbable Stents Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Fully Bioresorbable Stents by Application
4.1 Fully Bioresorbable Stents Market Segment by Application
4.1.1 Hospital
4.1.2 Surgical Centers
4.1.3 Others
4.2 Global Fully Bioresorbable Stents Market Size by Application
4.2.1 Global Fully Bioresorbable Stents Market Size Overview by Application (2018-2029)
4.2.2 Global Fully Bioresorbable Stents Historic Market Size Review by Application (2018-2023)
4.2.3 Global Fully Bioresorbable Stents Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fully Bioresorbable Stents Sales Breakdown by Application (2018-2023)
4.3.2 Europe Fully Bioresorbable Stents Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Fully Bioresorbable Stents Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Fully Bioresorbable Stents Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Fully Bioresorbable Stents Sales Breakdown by Application (2018-2023)
5 North America Fully Bioresorbable Stents by Country
5.1 North America Fully Bioresorbable Stents Historic Market Size by Country
5.1.1 North America Fully Bioresorbable Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Fully Bioresorbable Stents Sales in Volume by Country (2018-2023)
5.1.3 North America Fully Bioresorbable Stents Sales in Value by Country (2018-2023)
5.2 North America Fully Bioresorbable Stents Forecasted Market Size by Country
5.2.1 North America Fully Bioresorbable Stents Sales in Volume by Country (2024-2029)
5.2.2 North America Fully Bioresorbable Stents Sales in Value by Country (2024-2029)
6 Europe Fully Bioresorbable Stents by Country
6.1 Europe Fully Bioresorbable Stents Historic Market Size by Country
6.1.1 Europe Fully Bioresorbable Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Fully Bioresorbable Stents Sales in Volume by Country (2018-2023)
6.1.3 Europe Fully Bioresorbable Stents Sales in Value by Country (2018-2023)
6.2 Europe Fully Bioresorbable Stents Forecasted Market Size by Country
6.2.1 Europe Fully Bioresorbable Stents Sales in Volume by Country (2024-2029)
6.2.2 Europe Fully Bioresorbable Stents Sales in Value by Country (2024-2029)
7 Asia-Pacific Fully Bioresorbable Stents by Region
7.1 Asia-Pacific Fully Bioresorbable Stents Historic Market Size by Region
7.1.1 Asia-Pacific Fully Bioresorbable Stents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Fully Bioresorbable Stents Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Fully Bioresorbable Stents Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Fully Bioresorbable Stents Forecasted Market Size by Region
7.2.1 Asia-Pacific Fully Bioresorbable Stents Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Fully Bioresorbable Stents Sales in Value by Region (2024-2029)
8 Latin America Fully Bioresorbable Stents by Country
8.1 Latin America Fully Bioresorbable Stents Historic Market Size by Country
8.1.1 Latin America Fully Bioresorbable Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Fully Bioresorbable Stents Sales in Volume by Country (2018-2023)
8.1.3 Latin America Fully Bioresorbable Stents Sales in Value by Country (2018-2023)
8.2 Latin America Fully Bioresorbable Stents Forecasted Market Size by Country
8.2.1 Latin America Fully Bioresorbable Stents Sales in Volume by Country (2024-2029)
8.2.2 Latin America Fully Bioresorbable Stents Sales in Value by Country (2024-2029)
9 Middle East and Africa Fully Bioresorbable Stents by Country
9.1 Middle East and Africa Fully Bioresorbable Stents Historic Market Size by Country
9.1.1 Middle East and Africa Fully Bioresorbable Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Fully Bioresorbable Stents Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Fully Bioresorbable Stents Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Fully Bioresorbable Stents Forecasted Market Size by Country
9.2.1 Middle East and Africa Fully Bioresorbable Stents Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Fully Bioresorbable Stents Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Fully Bioresorbable Stents Products Offered
10.1.5 Abbott Recent Development
10.2 Lepu Medical Technology
10.2.1 Lepu Medical Technology Company Information
10.2.2 Lepu Medical Technology Introduction and Business Overview
10.2.3 Lepu Medical Technology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lepu Medical Technology Fully Bioresorbable Stents Products Offered
10.2.5 Lepu Medical Technology Recent Development
10.3 Shandong Hua'an Biotechnology
10.3.1 Shandong Hua'an Biotechnology Company Information
10.3.2 Shandong Hua'an Biotechnology Introduction and Business Overview
10.3.3 Shandong Hua'an Biotechnology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shandong Hua'an Biotechnology Fully Bioresorbable Stents Products Offered
10.3.5 Shandong Hua'an Biotechnology Recent Development
10.4 MicroPort
10.4.1 MicroPort Company Information
10.4.2 MicroPort Introduction and Business Overview
10.4.3 MicroPort Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 MicroPort Fully Bioresorbable Stents Products Offered
10.4.5 MicroPort Recent Development
10.5 Lifetech Scientific
10.5.1 Lifetech Scientific Company Information
10.5.2 Lifetech Scientific Introduction and Business Overview
10.5.3 Lifetech Scientific Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lifetech Scientific Fully Bioresorbable Stents Products Offered
10.5.5 Lifetech Scientific Recent Development
10.6 Beijing Advanced Medical Technologies
10.6.1 Beijing Advanced Medical Technologies Company Information
10.6.2 Beijing Advanced Medical Technologies Introduction and Business Overview
10.6.3 Beijing Advanced Medical Technologies Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Beijing Advanced Medical Technologies Fully Bioresorbable Stents Products Offered
10.6.5 Beijing Advanced Medical Technologies Recent Development
10.7 Shanghai Bio-heart Biological Technology
10.7.1 Shanghai Bio-heart Biological Technology Company Information
10.7.2 Shanghai Bio-heart Biological Technology Introduction and Business Overview
10.7.3 Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai Bio-heart Biological Technology Fully Bioresorbable Stents Products Offered
10.7.5 Shanghai Bio-heart Biological Technology Recent Development
10.8 Elixir Medical Corporation
10.8.1 Elixir Medical Corporation Company Information
10.8.2 Elixir Medical Corporation Introduction and Business Overview
10.8.3 Elixir Medical Corporation Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Elixir Medical Corporation Fully Bioresorbable Stents Products Offered
10.8.5 Elixir Medical Corporation Recent Development
10.9 Biotronic
10.9.1 Biotronic Company Information
10.9.2 Biotronic Introduction and Business Overview
10.9.3 Biotronic Fully Bioresorbable Stents Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biotronic Fully Bioresorbable Stents Products Offered
10.9.5 Biotronic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fully Bioresorbable Stents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fully Bioresorbable Stents Industrial Chain Analysis
11.4 Fully Bioresorbable Stents Market Dynamics
11.4.1 Fully Bioresorbable Stents Industry Trends
11.4.2 Fully Bioresorbable Stents Market Drivers
11.4.3 Fully Bioresorbable Stents Market Challenges
11.4.4 Fully Bioresorbable Stents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fully Bioresorbable Stents Distributors
12.3 Fully Bioresorbable Stents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
